Literature DB >> 7846616

Parathyroid adenoma weight and the risk of death after treatment for primary hyperparathyroidism.

G Hedbäck1, A Odén, L E Tisell.   

Abstract

BACKGROUND: Patients operated on for primary hyperparathyroidism run an increased risk of death, as was found in a previous long-term follow-up of 896 patients.
METHODS: In the present study the adenoma weight was determined in 713 patients with single parathyroid gland disease operated on between 1956 and 1982 and followed up in 1986. The adenoma weight was investigated for its usefulness as a prognostic factor.
RESULTS: The analysis showed that the adenoma weight was significantly related to the risk of death (p < 0.001). Also a relationship was noted between glandular weight and preoperative serum calcium level (p < 0.001), although the serum calcium level had no predictive value in relation to the risk of death beyond that of the adenoma weight. The risk increase was also estimated as a function of adenoma weight. A moderate adenoma weight increase in a patient with primary hyperparathyroidism was found to imply an increased risk of death, corresponding to the increased risk of smokers as compared with nonsmokers.
CONCLUSIONS: The results of this study support surgical treatment at an early stage of primary hyperparathyroidism.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7846616     DOI: 10.1016/s0039-6060(05)80076-5

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  13 in total

1.  Changing biochemical presentation of primary hyperparathyroidism.

Authors:  Martin Almquist; Anders Bergenfelz; Hans Mårtensson; Mark Thier; Erik Nordenström
Journal:  Langenbecks Arch Surg       Date:  2010-07-10       Impact factor: 3.445

2.  Improving diagnostic recognition of primary hyperparathyroidism with machine learning.

Authors:  Yash R Somnay; Mark Craven; Kelly L McCoy; Sally E Carty; Tracy S Wang; Caprice C Greenberg; David F Schneider
Journal:  Surgery       Date:  2016-12-15       Impact factor: 3.982

3.  Challenging neck mass: non-functional giant parathyroid adenoma.

Authors:  Chiara Mossinelli; Alberto Maria Saibene; Loredana De Pasquale; Alberto Maccari
Journal:  BMJ Case Rep       Date:  2016-08-17

4.  Risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow up study.

Authors:  Charlotte L Mollerup; Peter Vestergaard; Vibe Gedsø Frøkjaer; Leif Mosekilde; Peer Christiansen; Mogens Blichert-Toft
Journal:  BMJ       Date:  2002-10-12

5.  Giant parathyroid tumours in primary hyperparathyroidism: a systematic review.

Authors:  Ho Kiu Grace Wong; Kate Shipman; Kimberley Allan; Andrew Ghabbour; Farzad Borumandi
Journal:  Langenbecks Arch Surg       Date:  2022-01-18       Impact factor: 3.445

6.  Correlation of biochemical markers of primary hyperparathyroidism with single adenoma weight and volume.

Authors:  F Kamani; A Najafi; S S Mohammadi; S Tavassoli; S P Shojaei
Journal:  Indian J Surg       Date:  2012-03-27       Impact factor: 0.656

7.  Serum levels of uric acid and diabetes mellitus influence survival after surgery for primary hyperparathyroidism: a prospective cohort study.

Authors:  Anders Bergenfelz; Anna Bladström; Mark Their; Erik Nordenström; Stig Valdemarsson; Johan Westerdahl
Journal:  World J Surg       Date:  2007-07       Impact factor: 3.352

8.  Clinical manifestations of primary hyperparathyroidism before and after parathyroidectomy. A case-control study.

Authors:  A K Chan; Q Y Duh; M H Katz; A E Siperstein; O H Clark
Journal:  Ann Surg       Date:  1995-09       Impact factor: 12.969

9.  THE VOLUME OF SOLITARY PARATHYROID ADENOMA IS RELATED TO PREOPERATIVE PTH AND 25OH-D3, BUT NOT TO CALCIUM LEVELS.

Authors:  A Gatu; C Velicescu; A Grigorovici; R Danila; V Muntean; S J Mogoş; V Mogoş; C Vulpoi; C Preda; D Branisteanu
Journal:  Acta Endocrinol (Buchar)       Date:  2017 Oct-Dec       Impact factor: 0.877

10.  Hyperparathyroidism: cancer and mortality.

Authors:  Soumik Goswami; Sujoy Ghosh
Journal:  Indian J Endocrinol Metab       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.